Stroke I

Published on 10/04/2015 by admin

Filed under Neurology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1363 times

Stroke I

Stroke refers to damage to the brain caused by abnormalities of blood supply. This presents with a rapidly developing focal neurological deficit, which may lead to coma or death. If this deficit lasts less than 24 h it is referred to as a transient ischaemic attack (TIA; p. 70).

Stroke is the third most common cause of death in developed countries. The incidence of first stroke is 2 per 1000 per year. The incidence increases with age. It is rare below 45 years of age and increases from 2 per 1000 per year for people aged 45–54 years to 10 per 1000 per year for those aged 65–74 years and to about 30 per 1000 per year in those aged over 80 years. About a quarter of these patients will be dead within 6 months (the majority of these within 1 month). Stroke is a major cause of disability; after their first stroke, 40% of surviving patients will be dependent at 6 months.

Stroke is not a single diagnosis. Strokes differ in terms of their aetiology and pathogenesis, the area of the brain affected and the resulting clinical deficit. These differences have implications for investigation, treatment and prognosis.

Pathogenesis

Cerebral infarction accounts for 80% of strokes, 15% are primary intracerebral haemorrhages and 5% are due to subarachnoid haemorrhages (p. 72).

Cerebral infarction

Cerebral infarction results from an interruption in blood supply to an area of the brain. This can be due to (Fig. 1):

Atheroma

Atheroma is an important factor in both embolic and thrombotic strokes. A similar pathological process, occurring in patients with the same risk factors, produces intracerebral small vessel disease.

The risk factors for atheroma, and other disease resulting from it, are given in Table 1. The most important risk factor is hypertension, with the risk increasing with the blood pressure.

Table 1 Risk factors for atheroma and relative risk of stroke

Risk factors for atheroma Relative risk of stroke
Hypertension 5
Diabetes 2
Smoking 3
Family history  
Cholesterol  
Excess alcohol intake 1–4

Atheroma commonly arises at the junctions of arteries, for example the carotid bifurcation and the point where the two vertebral arteries join to form the basilar artery (Fig. 2).

The build up of atheroma may lead to narrowing of the arteries. This is usually a gradual process and anastomotic channels can develop, either around the circle of Willis (Fig. 2) or with enlargement of meningeal anastomoses. Stenosis can develop and proceed to occlusion of a vessel without resulting in cerebral ischaemia. However, the atheromatous plaque can lead to cerebral ischaemia in several ways:

Intracerebral haemorrhage

Intracerebral haemorrhage is usually due to hypertension (primary intracerebral haemorrhage). This occurs when small penetrating arteries within the brain rupture at sites of weakness, as a result of lipohyalinosis and microaneurysms (Charcot–Bouchard aneurysms). Intracerebral haemorrhages occur most frequently in the basal ganglia (50%; Fig. 3), lobar white matter (20%), pons (10%) and cerebellum (10%).

Ruptured saccular aneurysms produce subarachnoid haemorrhage (p. 72). However, sometimes the direction of rupture of an aneurysm can result in most of the haemorrhage being intracerebral rather than subarachnoid. Arteriovenous malformations can rupture and produce intracerebral haemorrhage. Patients with bleeding disorders, particularly related to drugs (anticoagulants and thrombolytics such as streptokinase), can develop intracerebral haemorrhages.

Development of an ischaemic stroke

Cerebral infarction occurs after a few minutes of ischaemia. The consequence of ischaemia depends on its duration and severity. This will vary within the affected area of the brain, with areas on the edge of the vascular territory of the affected vessel being relatively less affected, sometimes called the ischaemic penumbra. Severe ischaemia will lead to cell death while less-affected cells may have the potential to survive. There is increasing evidence that excitotoxic amino acids may be involved in the pathogenesis of the cell death. Other biochemical factors, such as the blood glucose, will also affect cell survival.

Areas of necrosis will then swell, so-called cytotoxic oedema, which may interfere with the perfusion of areas in the penumbra. This swelling increases over 5 days and then gradually clears. If large areas of brain are affected (e.g. a middle cerebral artery occlusion; p. 66), this may produce a significant mass effect causing a further deterioration due to cerebral herniation. This is also seen in intracerebral haemorrhage where the haematoma increases the mass effect.

By 3 weeks, the haemodynamic changes that led to the stroke are stable and the recovery phase of the stroke is dependent on recovery of the ischaemic penumbra and remodelling of brain function. The area of infarction shrinks, undergoing the process of gliosis. In patients who have had strokes affecting small deep perforating vessels, this process of gliosis leads to the formation of small lakes of fluid, so-called ‘lacunes’.